Comera Competitors

Delisted . USA . 
Stock . Comera Life Sciences
Comera Life Sciences competes with SAB Biotherapeutics, Processa Pharmaceuticals, Third Harmonic, Indaptus Therapeutics, and Rezolute; as well as few others. The company conducts business under Biotechnology sector and is part of Health Care industry. Analyzing Comera Life competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Comera Life to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Comera Life competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
0.000.000.00
Details
Intrinsic
Valuation
LowRealHigh
0.000.000.00
Details

Comera Life Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Comera Life and its competitors represents the degree of relationship between the price movements of corresponding pink sheets. A correlation of about +1.0 implies that the price of Comera and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Comera Life Sciences does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
THRD
+ 0.92
PCSA
FBRX
+ 0.92
THRD
FBRX
+ 0.91
PCSA
THRD
+ 0.84
SABS
FBRX
+ 0.83
SABS
PCSA
+ 0.82
SABS
  
High negative correlations   
GNLX
- 0.81
THRD
GNLX
- 0.81
SABS
GNLX
- 0.73
PCSA
GNLX
- 0.71
FBRX
GNLX
- 0.66
INDP
DYAI
- 0.5
GNLX

Risk-Adjusted Indicators

There is a big difference between Comera Pink Sheet performing well and Comera Life Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Comera Life's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
SABS  6.17 (0.17) 0.00 (0.45) 0.00 
 0.00 
 13.14 
(9.41)
 101.06 
PCSA  4.24 (1.04) 0.00 (3.54) 0.00 
 0.00 
 10.00 
(9.88)
 32.56 
FRTX  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
THRD  3.81 (1.56) 0.00  7.10  0.00 
 0.00 
 6.07 
(8.13)
 40.45 
INDP  3.36 (0.18) 0.00 (4.21) 0.00 
 0.00 
 6.33 
(6.59)
 20.25 
RZLT  3.00 (0.26) 0.00 (0.36) 0.00 
 0.00 
 5.62 
(6.49)
 22.04 
TPST  2.79  0.22  0.00 (0.01) 0.00 
 0.00 
 5.13 
(5.49)
 26.61 
FBRX  5.33 (1.80) 0.00 (2.73) 0.00 
 0.00 
 9.14 
(12.11)
 32.20 
GNLX  5.01  0.98  0.15  0.32  5.03 
(6.19)
 12.60 
(10.00)
 36.53 
DYAI  4.01  0.20  0.05  0.14  4.65 
(4.67)
 6.96 
(8.59)
 46.69 
All Fundamental Data

Comera Life Competitive Analysis

The better you understand Comera Life competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Comera Life's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Comera Life's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
SABS PCSA THRD INDP RZLT TPST FBRX GNLX DYAI CING
 1.23 
 1.61 
SAB
 2.17 
 0.45 
Processa
 0.58 
 3.43 
Third
 3.57 
 0.81 
Indaptus
 3.74 
 3.60 
Rezolute
 1.20 
 0.84 
Tempest
 3.33 
 5.80 
Forte
 5.03 
 3.40 
Genelux
 2.82 
 1.38 
Dyadic
 1.10 
 3.59 
Cingulate
Market Volatility
(90 Days Market Risk)
Very risky
Dangerous
Relatively risky
Very risky
Moderately volatile
Moderately volatile
Risky
Relatively risky
Dangerous
Somewhat reliable
Market Performance
(90 Days Performance)
Very Weak
Very Weak
Very Weak
Very Weak
Very Weak
Weak
Very Weak
OK
Very Weak
Very Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
High
Very High
Low
Low
Low
Very High
Above Average
Low
About Average
Very High
Current Valuation
(Equity Enterprise Value)
Under Valued
Under Valued
Under Valued
Under Valued
Under Valued
Under Valued
Over Valued
Under Valued
Under Valued
Under Valued
Buy or Sell Advice
(Average Analysts Consensus)
Strong Buy
Buy
Strong Buy
Buy
Strong Buy
Strong Buy
Strong Buy
Strong Buy
Buy
Strong Buy
Trade Advice
(90 Days Macroaxis Advice)
Strong Hold
Strong Sell
Strong Sell
Strong Sell
Hold
Hold
Cautious Hold
Hold
Hold
Cautious Hold
Current Ratio
1.72
8.89
23.59
9.18
61.78
3.05
25.67
N/A
4.98
10.94
Net Asset
83.94 M
5.79 M
277.71 M
14.92 M
132.74 M
51.6 M
38.98 M
27.89 M
8.22 M
3.49 M
Profit Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
EBITDA
(38.13 M)
(11.46 M)
(30.79 M)
(16.38 M)
(68.42 M)
(28.78 M)
(32.48 M)
(26.46 M)
(8.19 M)
(22.95 M)
Operating Margin
-34.23
N/A
N/A
N/A
N/A
N/A
N/A
N/A
-5.28
N/A
Current Valuation
(11.11 M)
(657.63 K)
(134.53 M)
4.12 M
133.01 M
32.02 M
22 M
98.54 M
37.17 M
4.13 M
Price To Book
0.4
0.57
0.54
1.9
2.29
3.18
4.1
3.95
12.23
1.16
Retained Earnings
(90.06 M)
(75.37 M)
(114.22 M)
(45.42 M)
(329.44 M)
(165.26 M)
(118.52 M)
(221.52 M)
(80.28 M)
(92.94 M)
Current Asset
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
50.41 M
N/A
Five Year Return
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
One Year Return
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Beta
0.45
0.75
2.87
1.11
0.96
-2.57
2.88
-1.46
0.72
-0.84
Number Of Employees
57
13
51
7
64
17
11
25
7
13
Shares Outstanding
9.23 M
4.74 M
45.06 M
14.12 M
60.54 M
43.64 M
6.39 M
34.54 M
29.48 M
3.65 M
Three Year Return
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash Flow From Operations
(25.12 M)
(8.06 M)
(20.43 M)
(13.41 M)
(57.37 M)
(27.36 M)
(28.71 M)
(20.27 M)
(6.73 M)
(15.04 M)
Annual Yield
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Debt
5.91 M
150.55 K
3.95 M
175.05 K
2.23 M
20.66 M
3.67 M
2.52 M
136.93 K
3.14 M
Return On Equity
-1.75
-2.12
-0.14
-1.4
-0.74
-6.92
-1.37
-0.97
-1.27
-2.74
Z Score
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return On Asset
-0.79
-1.13
-0.11
-0.74
-0.43
-0.77
-0.68
-0.49
-0.46
-1.04
Number Of Shares Shorted
67.69 K
236.15 K
3.66 M
78.46 K
1.81 M
2.11 M
28.28 K
2.3 M
120.64 K
133.39 K
Book Value Per Share
4.0
1.14
6.59
0.59
1.65
0.43
6.42
0.97
0.2
3.95
Current Liabilities
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
596 K
N/A
Total Asset
83.94 M
5.79 M
277.71 M
14.92 M
132.74 M
51.6 M
38.98 M
27.89 M
8.22 M
3.49 M
Debt To Equity
0.16
0.001
7.81
0.004
0.001
0.49
N/A
N/A
7.04
0.084
Short Ratio
0.58
0.29
1.48
2.23
5.38
2.64
0.48
9.77
6.73
1.03
Target Price
14.0
6.0
4.5
8.5
13.11
18.75
107.0
18.4
6.0
35.4
Shares Owned By Institutions
28.68
2.08
90.88
14.51
84.38
15.53
80.06
14.12
16.01
2.82
Market Capitalization
15.04 M
2.12 M
155.45 M
11.39 M
226.4 M
36.4 M
38.36 M
123.65 M
33.6 M
13.24 M
Price To Earnings To Growth
N/A
-0.12
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Price To Earning
N/A
N/A
23.13
N/A
N/A
0.23
N/A
N/A
-18.7
N/A
Price To Sales
9.94
N/A
N/A
N/A
N/A
N/A
N/A
15455.84
12.49
N/A
Net Income
(42.19 M)
(11.12 M)
(30.82 M)
(15.42 M)
(68.46 M)
(29.49 M)
(31.48 M)
(28.3 M)
(6.8 M)
(23.53 K)
Earnings Per Share
-6.3
-4.8
-0.97
-1.7
-1.23
-1.53
-16.38
-0.94
-0.27
-43.22
Shares Owned By Insiders
19.15
5.71
9.12
42.92
13.4
0.16
9.71
16.58
30.21
3.3
Revenue
2.24 M
N/A
N/A
N/A
N/A
N/A
N/A
170 K
2.9 M
N/A
Working Capital
48.09 M
4.9 M
267.03 M
11.22 M
119.05 M
30.95 M
34.66 M
17.65 M
5.82 M
856.85 K
Ten Year Return
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash And Equivalents
16.62 M
12.06 M
112.73 M
33.01 M
150.41 M
51.62 M
38.55 M
N/A
15.64 M
8.2 M
Cash Per Share
0.39
0.76
25.53
4.0
3.87
4.95
1.89
N/A
0.55
0.73
Gross Profit
(25.38 M)
N/A
N/A
N/A
N/A
N/A
N/A
8 K
807.11 K
(10.1 M)
Day Typical Price
1.63
0.45
3.47
0.8
3.65
0.84
5.86
3.45
1.44
3.62
Accumulation Distribution
6168.35
5204.15
21776.49
321.9
33551.72
16819.55
2008.6
17986.37
9937.65
2479.35
Market Facilitation Index
0.0
0.0
N/A
0.0
0.0
N/A
0.0
0.0
0.0
0.0
Daily Balance Of Power
(0.17)
(0.20)
(0.14)
(0.75)
(0.50)
0.3333
(0.65)
(0.41)
(0.24)
(0.24)
Period Momentum Indicator
(0.02)
(0.01)
(0.02)
(0.03)
(0.14)
0.01
(0.20)
(0.18)
(0.04)
(0.04)
Rate Of Daily Change
0.99
0.98
0.99
0.96
0.96
1.01
0.97
0.95
0.97
0.99
Day Median Price
1.64
0.44
3.49
0.8
3.67
0.84
5.9
3.48
1.47
3.64
Price Action Indicator
(0.04)
N/A
(0.07)
(0.01)
(0.14)
0.01
(0.20)
(0.17)
(0.11)
(0.07)
Coefficient Of Variation
(4,727)
(539.37)
(415.23)
(2,411)
(936.15)
(131,276)
(357.99)
987.84
5850.11
(2,857)
Mean Deviation
6.17
4.24
3.81
3.36
3.0
2.79
5.33
5.01
4.01
2.73
Jensen Alpha
(0.17)
(1.04)
(1.56)
(0.18)
(0.26)
0.2237
(1.80)
0.9764
0.2021
(0.13)
Total Risk Alpha
1.61
(0.11)
(0.47)
0.5178
0.2387
0.6995
(0.76)
1.82
1.17
0.5052
Sortino Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
0.1512
0.0471
N/A
Downside Variance
N/A
N/A
N/A
N/A
N/A
N/A
N/A
29.24
26.1
N/A
Standard Deviation
10.99
5.78
6.32
4.15
4.03
4.23
6.74
6.77
6.35
3.86
Kurtosis
12.66
2.52
8.43
(0.23)
1.56
6.93
(0.05)
1.76
14.68
4.58
Potential Upside
13.14
10.0
6.07
6.33
5.62
5.13
9.14
12.6
6.96
4.82
Treynor Ratio
(0.45)
(3.54)
7.1
(4.21)
(0.36)
(0.01)
(2.73)
0.3192
0.1352
(1.27)
Maximum Drawdown
101.06
32.56
40.45
20.25
22.04
26.61
32.2
36.53
46.69
24.4
Variance
120.74
33.37
39.93
17.26
16.25
17.89
45.48
45.84
40.28
14.89
Market Risk Adjusted Performance
(0.44)
(3.53)
7.11
(4.20)
(0.35)
0.0021
(2.72)
0.3292
0.1452
(1.26)
Risk Adjusted Performance
(0.01)
(0.15)
(0.19)
(0.03)
(0.08)
0.0074
(0.23)
0.0942
0.0231
(0.02)
Skewness
(0.26)
0.9736
(2.30)
0.228
0.7353
1.39
0.1769
0.9197
2.68
1.41
Semi Deviation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
5.03
4.65
N/A
Information Ratio
(0.01)
(0.16)
(0.22)
(0.01)
(0.07)
0.0305
(0.26)
0.1208
0.0379
(0.0007)
Value At Risk
(9.41)
(9.88)
(8.13)
(6.59)
(6.49)
(5.49)
(12.11)
(10.00)
(8.59)
(4.97)
Expected Short fall
N/A
N/A
N/A
N/A
N/A
N/A
N/A
(6.19)
(4.67)
N/A
Downside Deviation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
5.41
5.11
N/A
Semi Variance
N/A
N/A
N/A
N/A
N/A
N/A
N/A
25.29
21.64
N/A

Comera Life Competition Performance Charts

Five steps to successful analysis of Comera Life Competition

Comera Life's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Comera Life Sciences in relation to its competition. Comera Life's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Comera Life in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Comera Life's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Comera Life Sciences, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Comera Life position

In addition to having Comera Life in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Business Supplies Thematic Idea Now

Business Supplies
Business Supplies Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Business Supplies theme has 24 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Business Supplies Theme or any other thematic opportunities.
View All  Next Launch
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Consideration for investing in Comera Pink Sheet

If you are still planning to invest in Comera Life Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Comera Life's history and understand the potential risks before investing.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Bonds Directory
Find actively traded corporate debentures issued by US companies
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY